Heidrun Potschka Selected Research

L 701324

5/2014

Pre-treatment with the NMDA receptor glycine-binding site antagonist L-701,324 improves pharmacosensitivity in a mouse kindling model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heidrun Potschka Research Topics

Disease

58	Epilepsy (Aura) 04/2022 - 04/2002
48	Seizures (Absence Seizure) 01/2022 - 04/2002
29	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 04/2002
19	Temporal Lobe Epilepsy 01/2021 - 01/2002
8	Drug Resistant Epilepsy 01/2022 - 04/2002
5	Myoclonic Epilepsies (Myoclonic Encephalopathy) 04/2022 - 01/2021
5	Partial Epilepsies (Epilepsy, Partial) 01/2020 - 07/2002
5	Central Nervous System Diseases (CNS Diseases) 05/2014 - 01/2005
4	Brain Diseases (Brain Disorder) 04/2022 - 02/2004
3	Body Weight (Weight, Body) 09/2020 - 01/2015
3	Mental Disorders (Mental Disorder) 12/2018 - 06/2006
3	Brain Ischemia (Cerebral Ischemia) 11/2016 - 10/2014
2	Ataxia (Dyssynergia) 04/2022 - 10/2004
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 06/2008
2	Breast Neoplasms (Breast Cancer) 06/2015 - 01/2005
2	Inflammation (Inflammations) 10/2014 - 08/2008
2	Schizophrenia (Dementia Praecox) 09/2011 - 08/2005
2	Neoplasms (Cancer) 08/2005 - 04/2005
1	COVID-19 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Tuberous Sclerosis (Bourneville's Disease) 01/2021
1	Gliosis 01/2021
1	Anhedonia 01/2021
1	Lennox Gastaut Syndrome 01/2021
1	Tremor (Tremors) 11/2020
1	Weight Loss (Weight Reduction) 02/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Epileptic Syndromes 01/2019

Drug/Important Bio-Agent (IBA)

29	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019 - 01/2002
23	Pharmaceutical PreparationsIBA 04/2022 - 04/2002
19	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2013 - 04/2002
11	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2004
10	Pilocarpine (Ocusert)FDA LinkGeneric 10/2019 - 04/2002
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2014
8	Phenobarbital (Luminal)FDA Link 01/2022 - 07/2002
8	Glutamic Acid (Glutamate)FDA Link 01/2021 - 06/2006
7	Kainic Acid (Kainate)IBA 01/2022 - 07/2002
6	Phenytoin (Dilantin)FDA LinkGeneric 10/2011 - 09/2002
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022 - 05/2008
5	Peptides (Polypeptides)IBA 03/2014 - 09/2011
4	LigandsIBA 01/2021 - 03/2010
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2014 - 04/2003
4	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 09/2011 - 07/2007
4	Levetiracetam (Keppra)FDA LinkGeneric 07/2009 - 04/2002
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2022 - 02/2010
3	4- (2'- methoxyphenyl)- 1- (2'- (N- 2'- pyridinyl)- p- (18F)fluorobenzamido )ethylpiperazineIBA 01/2021 - 10/2018
3	AWD 131-138IBA 11/2020 - 10/2004
2	CorticosteroneIBA 01/2022 - 01/2018
2	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 08/2015
2	5-HT1A Serotonin ReceptorIBA 01/2021 - 10/2018
2	SaccharinIBA 01/2021 - 01/2019
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2020 - 01/2019
2	perampanelIBA 01/2019 - 04/2016
2	Deoxyglucose (2 Deoxy D glucose)IBA 12/2018 - 10/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2015 - 01/2010
2	Neuroprotective AgentsIBA 10/2014 - 09/2011
2	Neuropeptide YIBA 10/2014 - 01/2004
2	Lacosamide FDA Link 07/2013 - 11/2006
2	Lamotrigine (Lamictal)FDA LinkGeneric 09/2012 - 07/2002
2	Erythropoietin FDA Link 12/2011 - 10/2011
2	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 09/2010 - 02/2010
2	polysialic acidIBA 06/2010 - 04/2008
2	PlasticsIBA 04/2008 - 07/2007
2	polysialyl neural cell adhesion moleculeIBA 04/2008 - 07/2007
2	Diazepam (Valium)FDA LinkGeneric 06/2003 - 10/2002
1	clemizoleIBA 04/2022
1	atalurenIBA 04/2022
1	Voltage-Gated Sodium ChannelsIBA 04/2022
1	lorcaserinIBA 04/2022
1	firocoxibIBA 01/2022
1	ProteomeIBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Everolimus FDA Link 01/2021
1	CannabidiolIBA 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	Investigational DrugsIBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	FenfluramineIBA 01/2021
1	Butyric Acid (Butanoic Acid)IBA 11/2020
1	Anti-Anxiety Agents (Anxiolytics)IBA 11/2020
1	Tramadol (K315)FDA LinkGeneric 02/2020
1	Toll-Like Receptor 4IBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	citrate-binding transport proteinIBA 01/2020
1	Citric Acid (Citrate)FDA LinkGeneric 01/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2019
1	AMPA Receptors (AMPA Receptor)IBA 01/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2018

Therapy/Procedure

10	Therapeutics 04/2022 - 08/2005
2	Electrodes (Electrode) 01/2022 - 02/2014
2	Ketogenic Diet 12/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2020 - 04/2009
2	Implanted Electrodes 08/2013 - 10/2011
1	Operative Surgical Procedures 01/2022
1	Neurosurgical Procedures 01/2022
1	Euthanasia (Mercy Killing) 02/2020
1	Precision Medicine 01/2020